Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease

NCT01101269 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Slow Recruitment

Conditions

Type 2 Diabetes

Interventions

DRUG: ACEI or ARB
DRUG: Lisinopril

Sponsor

University of Virginia